Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

A. Chiappella, M. Martelli, E. Angelucci, E. Brusamolino, A. Evangelista, A.M. Carella, C. Stelitano, G. Rossi, M. Balzarotti, F. Merli, G. Gaidano, V. Pavone, L. Rigacci, F. Zaja, A. D'Arco, N. Cascavilla, E. Russo, A. Castellino, M. Gotti, A.G. CongiuM.G. Cabras, A. Tucci, C. Agostinelli, G. Ciccone, S.A. Pileri, U. Vitolo

Research output: Contribution to journalArticlepeer-review

Cite this